CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

Name: CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
License: Public Domain

Beijing GoBroad Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

refractory lupus nephritis, systemic sclerosis, primary sjogren's syndrome combined with pulmonary hypertension

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 343840
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.